The UK government has secured 150,000 doses of the mpox vaccine from Bavarian Nordic to strengthen its defenses against the virus, prioritizing individuals at higher risk of exposure. The move comes as the World Health Organization (WHO) declared mpox a global health emergency, with a significant surge in cases, particularly in the Democratic Republic of Congo.
Danish biotech firm Bavarian Nordic plans to increase production of its mpox vaccine to address the global health emergency declared by the WHO. The company will work with international health organizations to ensure fair access to the vaccine, particularly in Africa where the virus is spreading rapidly.
Danish drugmaker Bavarian Nordic announced its readiness to produce up to 10 million doses of its mpox vaccine by 2025 following the World Health Organization’s declaration of a global health emergency due to a surge in the virus in Africa. The company currently has 500,000 doses in stock and awaits orders from concerned countries before initiating production.
